WANG HEMU has a total of 15 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in China, EPO (European Patent Office) and Singapore. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are ION CHANNEL INNOVATIONS LLC, ETUBICS CORP and MOSCA JOSEPH D.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Singapore | 3 | |
#4 | United States | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Medical preparations | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Yang Jun | 15 |
#2 | Wang Changhua | 15 |
#3 | Wang Hemu | 15 |
Publication | Filing date | Title |
---|---|---|
CN105797151A | High-dose hepatitis b vaccine based on recombination hansenula polymorpha | |
CN105727280A | Hepatitis b treatment vaccine of heat inactivation full-recombinant hansenula polymorpha based on HBsAg expression | |
CN105727279A | Therapeutic hepatitis B vaccine based on heat-inactivated whole recombinant hansenula polymorpha cells expressing HBsAg and HBcAg |